Figure 9.Correlations between the methylation model and clinical characteristics. (A) The prognostic model. (B) Nomogram for predicting the probability of 1-, 3-, and 5-year overall survival of patients with LUAD. (C) The recurrent model. (D) Nomogram for predicting the probability of 1-, 3-, and 5-year disease-free survival of patients with LUAD. LUAD, lung adenocarcinoma.
